Lorvotuzumab mertansine Completed Phase 1 Trials for Multiple Myeloma (MM) Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 1 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| https://clinicaltrials.gov/ct2/show/ | BB-10901 in Treating Patients With Relapsed and/or Refractory Multiple Myeloma | |
| https://clinicaltrials.gov/ct2/show/ | IMGN901 in Combination With Lenalidomide and Dexamethasone |